Osimert 80 mg (Osimertinib) Tablets is a targeted anticancer drug made by Everest Pharmaceuticals Ltd. This drug contains osimertinib, which is a 3rd-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) meant to treat particular cases of non-small cell lung cancer (NSCLC) with some mutations of EGFR gene. Osimertinib specifically targets cancer cells with certain mutations instead of the majority of other cells, in contrast to chemotherapy.
The physician can prescribe Osimert 80 mg tablets to adults with positive mutation of EGFR NSCLC after proper biomarker test shows that the tumor has an appropriate mutation. It can be administered for either early or advanced stages following surgery, depending on the patient’s condition and current professional recommendations.
This web page offers educational information concerning Osimert 80 mg (Osimertinib), such as approved uses, mechanism of action, dose, precaution, adverse effects, storage instructions, etc. This data is meant to help patients and caregivers understand Osimert 80 mg better.
When prescribed appropriately by an oncologist, Osimert 80 mg offers several important benefits.
This medication only attacks the cancer cells containing specific mutations in EGFR and not other rapidly dividing cells. This drug employs a focused strategy intended for particular patients rather than a general one like chemotherapy.
The medicine is taken by mouth once daily, making treatment more convenient than therapies requiring intravenous administration.
Osimertinib has activity against specific EGFR resistance mutations, including T790M, when used according to approved indications and clinical guidance.
Osimertinib has the potential to cross the blood-brain barrier better than certain previous EGFR inhibitors, thereby proving valuable for the selected population of patients with NSCLC harboring an EGFR mutation.
Because treatment is based on genetic testing rather than cancer location alone, osimertinib represents an example of precision medicine, allowing therapy to be matched to the molecular characteristics of the tumor.
The active ingredient in Osimert 80 mg tablets is osimertinib, a selective, irreversible EGFR tyrosine kinase inhibitor of the third generation.
It acts by focusing on abnormally functioning EGFR proteins generated due to specific gene mutations causing the development and spreading of particular non-small cell lung cancers. In this way, the drug prevents the development of cancerous cells.
Use of the drug must occur following proper tests to confirm the presence of an approved EGFR mutation.
Cancer cells with certain EGFR (Epidermal Growth Factor Receptor) mutations receive continuous growth signals that allow them to multiply uncontrollably.
Osimertinib works by:
All lung cancer patients do not benefit from Osimertinib. Before initiating therapy with osimertinib, molecular testing is performed by medical professionals in order to check if the tumor has EGFR mutation.
Not all lung cancers respond to osimertinib. Before starting treatment, doctors typically perform molecular testing to determine whether the tumor carries an EGFR mutation that is appropriate for this therapy.
Common EGFR mutations include:
Without confirmed EGFR mutation testing, Osimertinib may not be an appropriate treatment choice.
Osimert 80 mg is a prescribed drug that should only be taken according to instructions provided by a licensed health care practitioner. The patient must not alter the intake of the medication without consulting a doctor. Follow-up visits and necessary monitoring will help ensure the drug is used safely.
An oncologist or another qualified healthcare professional should always determine the dose and duration of treatment.
The commonly recommended adult dose is:
Treatment is usually continued until:
Do not change the dose or stop taking the medicine unless instructed by your healthcare provider.
If you experience serious side effects, your doctor might:
Dose adjustments should only be made under medical supervision.
To make sure the medication functions as intended:
Get in touch with your pharmacist or healthcare professional if you don’t know what to do after missing a dosage.
Contact your doctor or seek emergency medical assistance right away if you unintentionally consume more than the recommended dosage. Take the medicine packaging with you if possible.
Depending on the manufacturer and local market availability, Osimertinib tablets may be available in different strengths.
Common strengths include:
Your doctor will prescribe the strength that is appropriate for your treatment plan.
Pack sizes can vary depending on the country, distributor, and manufacturer.
Typical packaging may include:
Always check the product packaging or consult your pharmacy to confirm the available pack size before purchasing.
For safe and effective use:
While taking Osimertinib, your healthcare provider may recommend monitoring based on your individual clinical situation. This may include:
The type and frequency of monitoring will depend on your overall health, medical history, and response to treatment.
Osimert 80 mg must be taken with the guidance of a trained physician who has knowledge about cancers. Do not give your drugs to other people even if they have identical symptoms to yours, as this may prove harmful to their health.
Osimert 80 mg (Osimertinib) Tablets is intended for adults with specific types of EGFR mutation-positive non-small cell lung cancer (NSCLC) when prescribed by a qualified healthcare professional.
People who may be eligible include:
Treatment decisions should always be individualized based on the patient’s overall health, cancer stage, previous treatments, and current clinical guidelines.
Do not take Osimert 80 mg unless it has been prescribed specifically for you.
This medicine may not be appropriate for:
Before beginning therapy, always go over your whole medical history with your healthcare professional.
Before using Osimert 80 mg, tell your healthcare provider if you have:
Regular monitoring may be required during treatment.
Osimertinib has been associated with serious lung inflammation in some patients.
Contact your healthcare provider immediately if you experience:
Osimertinib may affect the electrical activity of the heart or heart function in some individuals.
Seek medical advice promptly if you experience:
Some patients may develop:
Report any new eye symptoms to your healthcare provider.
Osimertinib may harm an unborn baby.
Always follow the advice provided by your healthcare provider regarding family planning.
Not everyone experiences side effects, and some side effects may be mild while others can be serious.
Commonly reported side effects may include:
These side effects are often manageable, but you should discuss persistent symptoms with your healthcare provider.
Seek immediate medical attention if you develop:
This is not a complete list of side effects. Always consult the prescribing information and your healthcare provider for full safety information.
Drug interactions can affect how Osimertinib works or increase the risk of side effects.
Tell your doctor about:
Certain medicines may affect Osimertinib levels in the body, while Osimertinib may also influence the effects of other medicines.
Never start or stop another medicine without discussing it with your healthcare provider.
Store Osimert 80 mg according to the instructions provided on the product packaging.
General recommendations include:
If you are unsure how to store the medicine, consult your pharmacist.
| Product Information | Details |
|---|---|
| Product Name | Osimert 80 mg Tablets |
| Generic Name | Osimertinib |
| Brand Name | Osimert |
| Strength | 80 mg |
| Dosage Form | Film-coated tablet |
| Drug Class | Third-generation EGFR Tyrosine Kinase Inhibitor (TKI) |
| Therapeutic Category | Targeted Anticancer Medicine |
| Manufacturer | Everest Pharmaceuticals Ltd. |
| Route of Administration | Oral |
| Prescription Status | Prescription medicine (requirements vary by country) |
Everest Pharmaceuticals Ltd. is a company engaged in the manufacturing of pharmaceutical products, including the production of oncological drugs. It is important to always check the pack, batch number, and expiration date before using the drug.
Selecting a reliable pharmacy is an essential step in ensuring that one receives proper medication. Our mission statement includes supplying genuine medicines and customer care services alongside informing our customers about their healthcare needs.
Our goal is to provide a dependable service while maintaining high standards of quality, safety, and professionalism.
We understand that timely access to medicines is important for many patients.
Delivery times may vary depending on the destination, customs procedures, courier services, and local regulations. Exact delivery dates cannot be guaranteed.
Medicine authenticity is essential for patient safety.
To help ensure confidence in every order:
If you have questions about product authenticity, our customer support team can provide additional guidance before your purchase.
Osimert 80 mg (Osimertinib) Tablets is generally supplied as a prescription medicine.
Depending on the laws and regulations in your country:
If you are unsure about the prescription requirements in your location, please contact our pharmacy team before placing your order.
We strive to provide a professional and patient-focused experience by offering:
Our focus is on helping patients access genuine medicines responsibly while encouraging consultation with qualified healthcare professionals whenever needed.
Ositemt 80 mg (Osimertinib) Tablets is a targeted drug that treats eligible adult patients with particular mutations in non-small cell lung cancer (NSCLC). It works by selectively inhibiting EGFR and thus treats some types of lung cancer when taken as per the indication.
Given the fact that Ositemt 80 mg Tablets are supposed to be taken under the guidance of a qualified medical professional, taking them must be preceded by the proper diagnosis of the condition. Follow-up, monitoring, and compliance with the treatment regimen are key aspects of treatment.
Osimert 80 mg (Osimertinib) tablets are a prescription medicine designed for the treatment of selected adult patients who have non-small cell lung cancer associated with an EGFR mutation. The drug must be used only under the prescription of a competent healthcare provider after the appropriate molecular test confirms eligibility for an EGFR mutation.
If you miss a dose:
If you are unsure, consult your doctor or pharmacist.
This medicine may not be suitable for:
Always discuss your medical history with your doctor before starting treatment.
Need Help?
Our friendly support team is here to assist you with orders, shipping, returns, product information, and any questions you may have. Contact us anytime, and we’ll be happy to help.
Reviews
There are no reviews yet.